Active Filter(s):
Details:
The proceeds will advance Metaphore's MIMiC drug discovery platform and build its pipeline for autoimmune, metabolic or oncology indications. The MIMiC™ platform drives unprecedented insights into molecular interactions to design new biomolecules for therapeutic benefit.
Lead Product(s): Undisclosed
Therapeutic Area: Immunology Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Undisclosed
Partner/Sponsor/Collaborator: Flagship Pioneering
Deal Size: $50.0 million Upfront Cash: Undisclosed
Deal Type: Financing May 16, 2023